{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-24-000755","form_type":"8-K","ticker":"IGC","cik":"0001326205","company_name":"IGC Pharma, Inc.","filed_at":"2024-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.611532+00:00","generated_at":"2026-05-31T13:23:53.536188+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"IGC Pharma extends loan agreement with O-Bank; facility fees cut to $84,000 from $120,000","bullets":["Extension effective July 8, 2024, extends term of existing Master Loan and Security Agreement under same terms.","Facility fees reduced to $84,000 from $120,000; no other material changes to the agreement.","The loan agreement was previously disclosed in July 2023 8-K; this amendment solely extends the term.","No new borrowing or change in principal amount; obligation remains under existing credit facility."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-24-000755","json":"https://secwatch.observer/filing/0001185185-24-000755.json","markdown":"https://secwatch.observer/filing/0001185185-24-000755.md","text":"https://secwatch.observer/filing/0001185185-24-000755.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326205/000118518524000755/0001185185-24-000755-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326205/000118518524000755/igc20240802_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:23:53.536188+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}